Arkolith/Insider Trading/COEP/Form 4

Calise Chris

Director, 10% OwnerCoeptis Therapeutics Holdings, Inc. (COEP) · full profile →Form 4 · filed Nov 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 28, 2022Grant(A)3.0M$1.00$3.0M3.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-068387) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML